Chemomab Therapeutics (CMMB) Receivables (2017 - 2019)
Chemomab Therapeutics (CMMB) posted Receivables of $408000.0 for Q4 2019, down 66.99% on a QoQ basis from $1.2 million in Q3 2019, and down 88.08% year-over-year from $3.4 million in Q4 2018.
Chemomab Therapeutics (CMMB) Receivables (2017 - 2019) Analysis & Trends
Chemomab Therapeutics' Receivables history runs 3 years deep, the most recent figure standing at $408000.0 for Q4 2019.
- Quarterly Receivables fell 88.08% year-over-year to $408000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $408000.0 (down 88.08% YoY) and the FY2019 annual result came in at $408000.0, down 88.08% from the prior year.
- Receivables was $408000.0 for Q4 2019 at Chemomab Therapeutics, down from $1.2 million in the prior quarter.
- Across five years, Receivables topped out at $3.4 million in Q4 2018 and bottomed at $408000.0 in Q4 2019.
- A 3-year average of $1.3 million and a median of $885000.0 in 2019 frame the typical range for Receivables.
- Annual changes were most pronounced in 2018 — Receivables jumped 725.06% — and 2019, when it tumbled 88.08%.
- Chemomab Therapeutics' Receivables stood at $415000.0 in 2017, then soared by 725.06% to $3.4 million in 2018, then tumbled by 88.08% to $408000.0 in 2019.
- Business Quant data shows CMMB's Receivables at $408000.0 in Q4 2019, $1.2 million in Q3 2019, and $885000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Chemomab Therapeutics | 124.14 Mn | 113.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 408,000.00 |
| Sep 30, 2019 | 1.24 Mn |
| Jun 30, 2019 | 885,000.00 |
| Dec 31, 2018 | 3.42 Mn |
| Dec 31, 2017 | 415,000.00 |